Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jun Watanabe

Showing results (621-630 of 687) with videos related to

Pageof 69
Sort By:
Japanese Journal of Clinical Oncology|December 5, 2021
Preoperative and postoperative prognostic factors of patients with stage II/III lower rectal cancer without neoadjuvant therapy in the clinical trial (JCOG0212)Masayuki Ohue, Shin Fujita, Junki Mizusawa, et al.
Spine|September 21, 2021
The Effect of Preoperative Nutritional Intervention for Adult Spinal Deformity PatientsShin Oe, Jun Watanabe, Tatsuya Akai, et al.
Acta Neuropathologica Communications|July 27, 2019
Dramatic response of BRAF V600E-mutant epithelioid glioblastoma to combination therapy with BRAF and MEK inhibitor: establishment and xenograft of a cell line to predict clinical efficacyYu Kanemaru, Manabu Natsumeda, Masayasu Okada, et al.
The Journal of Clinical Investigation|May 30, 2023
Therapeutic targeting of metabolic vulnerabilities in cancers with MLL3/4-COMPASS epigenetic regulator mutationsZibo Zhao, Kaixiang Cao, Jun Watanabe, et al.
Transboundary and Emerging Diseases|May 15, 2021
Outbreak of equine pythiosis in a southeastern region of Brazil: Environmental isolation and phylogenyGiselle Souza da Paz, Gabriel Gasparini Camargo, José Eduardo Cury, et al.
Cancer Science|July 26, 2017
Novel orally bioavailable EZH1/2 dual inhibitors with greater antitumor efficacy than an EZH2 selective inhibitorDaisuke Honma, Osamu Kanno, Jun Watanabe, et al.
Digestion|March 3, 2026
Therapeutic Potential of the Low-FODMAP Diet in Functional Dyspepsia: A Systematic ReviewRyo Katsumata, Satoshi Shinozaki, Tadayuki Oshima, et al.
Nature Reviews. Gastroenterology & Hepatology|March 15, 2024
Future direction of total neoadjuvant therapy for locally advanced rectal cancerYoshinori Kagawa, J Joshua Smith, Emmanouil Fokas, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 3, 2008
Secreted CXCL1 is a potential mediator and marker of the tumor invasion of bladder cancerHiroaki Kawanishi, Yoshiyuki Matsui, Masaaki Ito, et al.
The Spine Journal : Official Journal of the North American Spine Society|August 21, 2024
A phase 3, randomized, double-blind, sham-controlled trial of SI-6603 (condoliase) in patients with radicular leg pain associated with lumbar disc herniationKee D Kim, Farshad Ahadian, Hamid Hassanzadeh, et al.
Pageof 69

Showing results (621-630 of 687) with videos related to

Sort By:
Pageof 69
Japanese Journal of Clinical Oncology|December 5, 2021
Preoperative and postoperative prognostic factors of patients with stage II/III lower rectal cancer without neoadjuvant therapy in the clinical trial (JCOG0212)Masayuki Ohue, Shin Fujita, Junki Mizusawa, et al.
Spine|September 21, 2021
The Effect of Preoperative Nutritional Intervention for Adult Spinal Deformity PatientsShin Oe, Jun Watanabe, Tatsuya Akai, et al.
Acta Neuropathologica Communications|July 27, 2019
Dramatic response of BRAF V600E-mutant epithelioid glioblastoma to combination therapy with BRAF and MEK inhibitor: establishment and xenograft of a cell line to predict clinical efficacyYu Kanemaru, Manabu Natsumeda, Masayasu Okada, et al.
The Journal of Clinical Investigation|May 30, 2023
Therapeutic targeting of metabolic vulnerabilities in cancers with MLL3/4-COMPASS epigenetic regulator mutationsZibo Zhao, Kaixiang Cao, Jun Watanabe, et al.
Transboundary and Emerging Diseases|May 15, 2021
Outbreak of equine pythiosis in a southeastern region of Brazil: Environmental isolation and phylogenyGiselle Souza da Paz, Gabriel Gasparini Camargo, José Eduardo Cury, et al.
Cancer Science|July 26, 2017
Novel orally bioavailable EZH1/2 dual inhibitors with greater antitumor efficacy than an EZH2 selective inhibitorDaisuke Honma, Osamu Kanno, Jun Watanabe, et al.
Digestion|March 3, 2026
Therapeutic Potential of the Low-FODMAP Diet in Functional Dyspepsia: A Systematic ReviewRyo Katsumata, Satoshi Shinozaki, Tadayuki Oshima, et al.
Nature Reviews. Gastroenterology & Hepatology|March 15, 2024
Future direction of total neoadjuvant therapy for locally advanced rectal cancerYoshinori Kagawa, J Joshua Smith, Emmanouil Fokas, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 3, 2008
Secreted CXCL1 is a potential mediator and marker of the tumor invasion of bladder cancerHiroaki Kawanishi, Yoshiyuki Matsui, Masaaki Ito, et al.
The Spine Journal : Official Journal of the North American Spine Society|August 21, 2024
A phase 3, randomized, double-blind, sham-controlled trial of SI-6603 (condoliase) in patients with radicular leg pain associated with lumbar disc herniationKee D Kim, Farshad Ahadian, Hamid Hassanzadeh, et al.
Pageof 69